Skip to main content
OpenTrials

Clinical trial condition

Advanced or Metastatic Breast Cancer

Explore clinical trials studying Advanced or Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

13 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Advanced or Metastatic Breast Cancer trial results

Recruiting

Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer

NCT06201234

Conditions
Advanced or Metastatic Breast Cancer, BRCA1 Mutation, BRCA2 Mutation, +11 more
Locations
  • Vinzenz Von Paul Kliniken gGmbH - Marienhospital Stuttgart, Baden-Wurttemberg, Germany
  • University Hospital Tübingen Tübingen, Baden-Wurttemberg, Germany
  • Rems-Murr-Klinik-Winnenden Winnenden, Baden-Wurttemberg, Germany
  • GRN Klinik Weinheim Weinheim, Baden-Württembergs, Germany
View all 36 locations
View Trial Details
Completed

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

NCT01226316

Conditions
AKT1, Adnexal Diseases, Advanced Solid Malignancy, +46 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Stanford, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site Aurora, Colorado, United States
View all 34 locations
View Trial Details
Completed

MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer

NCT03767335

Conditions
Advanced or Metastatic Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Holy Cross Hospital Inc. Fort Lauderdale, Florida, United States
  • Detroit Clinical Research Center Farmington Hills, Michigan, United States
  • Washington University St Louis, Missouri, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 27 locations
View Trial Details
Completed

Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.

NCT02154776

Conditions
Advanced or Metastatic Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of California at Los Angeles UCLA SC Los Angeles, California, United States
  • Horizon Oncology Center SC Lafayette, Indiana, United States
  • Medical University of South Carolina SC Charleston, South Carolina, United States
  • South Texas Accelerated Research Therapeutics SC San Antonio, Texas, United States
View Trial Details

Related conditions